2026-03-31
19Recently, Frost & Sullivan, in collaboration with the Shanghai Synthetic Biology Industry Association, officially released the Shanghai Synthetic Biology and Bio-Manufacturing Industry Development White Paper (2025). This white paper systematically reviews Shanghai's strategic layout, development pathways, and future opportunities in this field, aiming to provide an authoritative reference for industry decision-making. Jiangsu JV Bio-Equipment Co., Ltd. (hereinafter referred to as "JV Bio"), as a representative enterprise in the upstream critical segments of the industrial chain, was successfully selected as a benchmark enterprise case in the White Paper.
This is not only an honor but also an authoritative recognition by the industry of JV Bio's technological breakthroughs and market contributions in the core segment of synthetic biology industrialization—the biological fermentation systems sector.
Throughout the entire process from "route design" to "industrial scale-up," the fermentation stage is the decisive factor that determines the commercial success or failure of a technology. A high-performance biological fermentation system is the core carrier that fully unlocks the production potential of engineered strains and serves as the sole critical hub connecting innovative R&D with large-scale production.
JV Bio has deep expertise in efficient bio-manufacturing, focusing on developing stainless steel biological fermentation systems covering the full range of scales. With proprietary agitation designs featuring "low shear, high-intensity mixing," combined gas aeration, and high-precision temperature control technologies, our systems provide customers with reliable platforms and precise regulation, enabling:
✅ Significant improvement in cell density and target product expression levels
✅ Assurance of process stability, reproducibility, and scalability
✅ Realization of the critical leap from "laboratory validation" to "industrial implementation"
One compelling example is JV Bio's successful delivery of an integrated, automated, high-performance downstream process development and production platform to one of the very few global synthetic biology companies with annual peptide production capacity at the ton-level. This platform covers all critical modules from purification loading to final product concentration, and is complemented by upstream process system equipment, ensuring full continuity and integrity of the process chain. Feedback from the partner company stated: "JV Bio's system is not only stable and reliable, but has also significantly improved product expression and purification efficiency during process scale-up, providing a solid guarantee for our rapid time-to-market."
This selection is not only a recognition of JV Bio's technological strength and service capabilities, but also inspires us to continue using process equipment innovation as our engine, accompanying more synthetic biology enterprises in bridging the "last mile" from laboratory to large-scale production, and jointly propelling China's synthetic biology industry steadily toward broader markets.
